Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
4(31%)
Results Posted
33%(2 trials)

Phase Distribution

Ph phase_3
1
8%
Ph not_applicable
10
77%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(5)
Completed(6)
Other(2)

Detailed Status

Completed6
Recruiting3
unknown2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (9.1%)
N/A10 (90.9%)

Trials by Status

completed646%
not_yet_recruiting18%
recruiting323%
unknown215%
active_not_recruiting18%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials

All 13 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
13